Department of Medicine | January 30, 2019
In this week's Update
New Way of Managing GI Bleeding - A Randomized Trial ; Dr. Freedman receives new R01 ; Important announcement about International Grants and Sponsored Activities ; Funding opportunities ; Faculty Meeting Recap and Save the Dates ; Other News of Interest ; and Calendar .
Research News and Updates
New Way of Managing GI Bleeding - A Randomized Trial
The management of lower gastrointestinal bleeding has changed little over the last 4 decades. Using video capsule endoscopy in a randomized clinical trial, against standard of care, it was shown that early use of a video capsule is nearly three times more effective at detecting where there is active bleeding, than conventional means. This has major implications for cost containment and improving patient care.

David Cave, MD, PhD, professor of medicine, and colleagues from the division of Gastroenterology, as well as the Departments of Quantitative Health Sciences and Emergency Medicine, were among the authors on this study, published in the Gastrointestinal Endoscopy Journal earlier this month .

Read more: full article and accompanying editorial .
Congratulations to Jane Freedman, MD, professor of medicine, division of Cardiovascular Medicine, on her recent R01 from the National Heart, Lung, and Blood Institute to study Long Non-coding RNA as Mediators of Metabolic Disease.
International Grants and Sponsored Activities

 The following announcement was made by Dean Flotte on Thursday, January 24. In case you missed it, please read below.

Last August, the NIH issued a directive to all researchers to “ disclose all forms of other support and financial interests, including support coming from foreign governments or other foreign entities...[on] all applications and progress reports. ” (See: “ NIH Foreign Influence Letter to Grantees ”). Other federal agencies–including the Depts. of Education, Commerce, Defense and Homeland Security–have similarly warned of the potential risks of foreign influence on universities and are following up with enforcement action. A recent New York Times  article  reported on warnings from an NIH-commissioned panel that research universities need to tighten security procedures to protect biomedical research from theft and exploitation and have an affirmative responsibility to investigate “foreign influences on research integrity.”
To minimize UMMS exposure, it is critical that faculty make the above disclosures through the  Summary Disclosure of Financial Interests   form. We are also strengthening our administrative processes regarding foreign activities and giving enhanced attention to the security of export-controlled or “dual use” technologies. We have tightened vendor review processes, adopted new procedures for screening foreign donors and gifts, and made it mandatory to share details about objectives and host details when traveling to higher risk countries. Further, effective immediately,  all proposed and renewing projects involving a  foreign component   (as defined by the NIH)  must complete the UMMS  Export Control Review form.
Faculty and academic administrators are expected to coordinate with the international subject area experts to ensure appropriate risk mitigation. 
Funding Opportunity
Reminder: Applications for the 2019 L’Oréal USA For Women in Science fellowship program will close on  Friday, February 1, 2019. 
The L’Oréal USA For Women in Science fellowship program honors female scientists at a critical stage in their careers with grants of $60,000 each. Since 2003, they’ve awarded 75 postdoctoral women scientists nearly $4 million in grants.  They're seeking five exceptional female scientists looking to advance their research and serve as role models for the next generation in STEM.
The application and more information about the L’Oréal USA For Women in Science program can be found at

Questions / Additional information, contact:
Faculty Meeting
Despite the wintery start to the morning, today, we kicked off this year's series of faculty meetings with a recognition ceremony, honoring recent promotions, awards, and achievements, along with presentations on a couple of Department updates. It was wonderful to see so many of you there!

A few images captured from the meeting are pictured below.

We look forward to seeing you at our next meeting in April.
Save the Dates: Upcoming 2019 Faculty Meetings
Friday, April 26
12:00-1:00 PM
Wednesday, July 24
7:30-8:30 AM
Friday, October 25
12:00-1:00 PM
Other News of Interest
UMass Medical School received $161 million in National Institute of Health funding for research last fiscal year, the sixth highest in Massachusetts.

For the full Worcester Business Journal article from January 23, click here .
DOM Calendar at a glance

February 1
Clinicopathologic Conference (CPC) Presentation
Justice Oranefo, Senior Resident
(Internal Medicine Residency Conference Room)
12:00 PM

 February 1
Division Chiefs Meeting
LRB 203
12:00-1:00 PM
Lunch will be served

February 5
Seminar in Nephrology
Apheresis in Renal Disease: Indications and Technology
Andre Kaplan, MD
Professor of Medicine
UConn Healthcare
1:00-2:00 PM

February 6
Research Lecture Series
Peter D. Crompton, MD, MPH
Investigator, Malaria Infection
Biology & Immunology Section
National Institute of Allergy and Infectious Diseases
LRB 316
12:00-1:00 PM

For full DOM calendar of events, click   here.
Upcoming Grand Rounds
* Please note: the January 31 session will be held in the Sherman Center Auditorium - AS2-2102.
Sessions will resume in the Hiatt Auditorium for the month of February.

January 31
Andrew Dreyfus
President & Chief Executive Officer
Blue Cross Blue Shield of Massachusetts 
Sherman Center Auditorium
12:00-1:00 PM

February 7
 Samir M. Parikh, MD
Associate Professor of Medicine
Harvard Medical School
Co-Director, Center for Vascular Biological Research
Beth Israel Deaconess Medical Center
Hiatt Auditorium – S1-608
12:00-1:00 PM

~ ~ ~

Contact Us